Vivos Therapeutics (VVOS) EBT Margin (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vivos Therapeutics | 9.87 Mn | 7.64 Mn | 3.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,108.00 |
| Dec 31, 2025 | -10,224.00 |
| Sep 30, 2025 | 5,162.00 |
| Jun 30, 2025 | -311.00 |
| Mar 31, 2025 | -5,167.00 |
| Dec 31, 2024 | -867.00 |
| Sep 30, 2024 | -2,016.00 |
| Jun 30, 2024 | 6,245.00 |
| Mar 31, 2024 | 2,107.00 |
| Dec 31, 2023 | -6,772.00 |
| Sep 30, 2023 | 9,942.00 |
| Jun 30, 2023 | -11,867.00 |
| Mar 31, 2023 | -49,620.00 |
| Dec 31, 2022 | 58,003.00 |
| Sep 30, 2022 | 3,913.00 |
| Jun 30, 2022 | -2,082.00 |
| Mar 31, 2022 | -44,020.00 |
| Dec 31, 2021 | 41,385.00 |
| Sep 30, 2021 | -3,005.00 |
| Jun 30, 2021 | 867.00 |
| Mar 31, 2021 | 9,088.00 |
| Dec 31, 2020 | -13,374.00 |
| Sep 30, 2020 | -1,184.00 |
| Jun 30, 2020 | 3,750.00 |